XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED BALANCE SHEETS (Unaudited - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 5,356,445 $ 3,591,109
Investments in debt securities, at amortized cost (fair value of $1,950,220) 1,949,204
Accounts receivable, net of allowances of $98,318 and $92,646, respectively 130,655 110,258
Prepaid expenses 271,276 210,673
Inventory prepayment 366,626 197,750
Inventory 659,867 94,701
Other current assets 36,240 36,240
Total Current Assets 8,770,313 4,240,731
Non-Current Assets    
Patent costs, net 251,363 137,557
Capitalized software costs 110,073 110,073
Property and equipment, net 125,200 119,744
Other non-current assets 82,719 81,779
TOTAL ASSETS 9,339,668 4,689,884
Current Liabilities    
Accounts payable and accrued expenses 148,982 275,660
Deferred revenue 30,000 30,000
Due to Parent and Affiliates 151,612 232,989
Related party convertible debt (0) 61,356
Total Current Liabilities 330,594 600,005
Non-Current Liabilities    
Deferred revenue 57,950 65,450
TOTAL LIABILITIES 388,544 665,455
Commitments and contingencies
Stockholders’ Equity    
Common stock (par value $0.00001, 50,000,000 shares authorized, and 12,917,239 and 7,307,157 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively) 129 73
Additional paid-in capital 21,975,594 14,330,343
Accumulated deficit (13,024,599) (10,305,987)
TOTAL STOCKHOLDERS’ EQUITY 8,951,124 4,024,429
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 9,339,668 $ 4,689,884